The global management of chronic pain, inflammation, and treatment-resistant physical discomfort has long depended on conventional pharmaceutical interventions such as non-steroidal anti-inflammatory drugs and heavy opioid analgesics. While these traditional medical options provide varying degrees of relief, they frequently introduce severe dependency risks, systemic side effect profiles, and declining long-term efficacy. In response to these […]